Each month the CSF Steering Committee selects the latest published original articles on RA, PsA, and axSpA, focusing on those with data on therapeutic interventions and those that have clinical impact.
RA Literature Highlights – March 2023
Tofacitinib, Baricitinib, Sarilumab, bDMARDs, tsDMARDs, BSRBR-RA
AxSpA Literature Highlights – February 2023
Bimekizumab, Secukinumab, TNF Inhibitor, bDMARD, Achilles Enthesitis
PsA Literature Highlights – January 2023
Bimekizumab, Secukinumab, Guselkumab, Safety, Efficacy, HRQoL, CIMPASI-1, CIMPASI-2, PSoHO, PsABIOnd, BE OPTIMAL, BE COMPLETE
